Literature DB >> 8158196

Worsening of myasthenia gravis on treatment with imipenem/cilastatin.

J O'Riordan, M Javed, C Doherty, M Hutchinson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158196      PMCID: PMC1072840          DOI: 10.1136/jnnp.57.3.383

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  4 in total

1.  Ciprofloxacin and myasthenia gravis.

Authors:  C J Mumford; L Ginsberg
Journal:  BMJ       Date:  1990-10-06

Review 2.  Drug therapy: Disorders of neuromuscular transmission caused by drugs.

Authors:  Z Argov; F L Mastaglia
Journal:  N Engl J Med       Date:  1979-08-23       Impact factor: 91.245

3.  Aggravation of myasthenia gravis by erythromycin.

Authors:  J R Absher; J F Bale
Journal:  J Pediatr       Date:  1991-07       Impact factor: 4.406

4.  Ampicillin may aggravate clinical and experimental myasthenia gravis.

Authors:  Z Argov; T Brenner; O Abramsky
Journal:  Arch Neurol       Date:  1986-03
  4 in total
  3 in total

1.  Neurological and Psychiatric Adverse Effects of Antimicrobials.

Authors:  Madison K Bangert; Rodrigo Hasbun
Journal:  CNS Drugs       Date:  2019-08       Impact factor: 5.749

Review 2.  Adverse effects of monobactams and carbapenems.

Authors:  G Alván; C E Nord
Journal:  Drug Saf       Date:  1995-05       Impact factor: 5.606

3.  Bulbar Myasthenia Gravis Superimposed in a Medullary Infarction Diagnosed by a Fiberoptic Endoscopic Evaluation of Swallowing With Simultaneous Tensilon Application.

Authors:  Sung-Jun Kim; Geun-Young Park; Yong-Min Choi; Dong-Gyun Sohn; Sae-Rom Kang; Sun Im
Journal:  Ann Rehabil Med       Date:  2017-12-28
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.